Latest Security News

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

QEM Limited has raised A$2.05 million through a strongly supported placement to accelerate its Julia Creek Vanadium and Energy Project, coinciding with the retirement of founding CEO Gavin Loyden and the appointment of Robert Cooper as his successor.

Knosys Limited is reshaping its future by focusing on its Libero library management platform, aiming to become a global leader through strategic simplification, AI innovation, and geographic expansion.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Elsight Limited has expanded its supply agreement with a European defence drone OEM to a total of US$9.63 million for 2025, positioning the company for profitability and cash flow break-even this year.

Uvre has cleared a crucial regulatory hurdle in its acquisition of New Zealand’s Waitekauri Gold Project, setting the stage for new leadership and exploration activities.

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.

Agrimin Limited has successfully raised $2.5 million through an oversubscribed equity placement to fund the strategic review of its Mackay Potash Project and explore new mineral opportunities.

Trigg Minerals has launched its maiden exploration program at the Antimony Canyon Project in Utah, aiming to unlock the potential of historically productive antimony mines with modern techniques.

Felix Gold Limited has confirmed its ability to produce premium-grade antimony concentrate with up to 69% purity from its Treasure Creek Project in Alaska, targeting production by late 2025. The results align with U.S. strategic mineral priorities amid a tightening global supply.